1. Home
  2. AGMH vs BMRA Comparison

AGMH vs BMRA Comparison

Compare AGMH & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGMH

AGM Group Holdings Inc.

N/A

Current Price

$0.79

Market Cap

5.0M

Sector

Technology

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.36

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGMH
BMRA
Founded
2015
1971
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.0M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
AGMH
BMRA
Price
$0.79
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
549.9K
185.7K
Earning Date
05-13-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$1.45
52 Week High
$18.10
$3.21

Technical Indicators

Market Signals
Indicator
AGMH
BMRA
Relative Strength Index (RSI) 29.48 67.98
Support Level N/A $2.05
Resistance Level $1.38 $2.58
Average True Range (ATR) 0.11 0.21
MACD -0.02 0.02
Stochastic Oscillator 0.21 84.72

Price Performance

Historical Comparison
AGMH
BMRA

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is a technology company engaged in technology hardware research and development, manufacturing, assembly, and sales. Its core business segments include research and development of blockchain-oriented ASIC chips, production of high-end crypto miners for Bitcoin and other cryptocurrencies, and Fintech software services. The Company mainly derives revenue from the sales of cryptocurrency mining machines and standardized computing equipment.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: